iih glp-1 Novel use of receptor agonist therapy for pediatric idiopathic intracranial hypertension: a case report Management of IIH. The treatment
Description
The goal isnt just short-term loss but sustainable health improvement
doi: 10.1042/BSR20171284 213 RobinsonALubitzIAtrakchi-BaranesDLicht-MuravaAKatselPLeroithDet al
Doustdar thinks the drug's edge in effectiveness over Wegovy, even if only a few percentage points, is meaningful, and said he's committed to launching CagriSema
During maintenance therapy, many patients notice their elevated heart rate naturally decreases even while continuing the medication
